PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis

Tim Rosenow1, Merel C J Oudraad, Conor P Murray

  • 11 School of Paediatrics and Child Health and.

Insights

A new quantitative method, Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF), accurately measures cystic fibrosis (CF) airway disease in young children. This sensitive and reproducible tool aids in assessing lung disease extent in pediatric CF patients.

Area of Science:

  • Pediatric Pulmonology
  • Radiology
  • Medical Imaging Analysis

Background:

  • Chest computed tomography (CT) is the standard for assessing cystic fibrosis (CF) airway disease.
  • Current outcome measures lack standardization for children under 6 years old.

Purpose of the Study:

  • To develop and validate the Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF) as a quantitative measure for pediatric CF airway disease.
  • To compare PRAGMA-CF with the existing CF-CT scoring method.

Main Methods:

  • PRAGMA-CF was applied to CT scans from the Australian Respiratory Early Surveillance Team for CF (AREST CF) cohort.
  • The method involved annotating a grid on axial slices to quantify bronchiectasis, mucous plugging, and trapped air.
  • Observer reliability and comparison with a validated standard were assessed using 30 scans each.

Main Results:

  • PRAGMA-CF demonstrated high intraobserver reliability for %Dis (0.93), %Bx (0.93), and %TA (0.96).
  • Changes in %Dis and %Bx measured by PRAGMA-CF correlated with neutrophil elastase presence at age 3.
  • CF-CT showed a correlation only for bronchiectasis score with neutrophil elastase.

Conclusions:

  • PRAGMA-CF is a sensitive and reproducible outcome measure for evaluating lung disease in very young children with CF.
  • This quantitative method offers a standardized approach for assessing airway disease in pediatric CF patients.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
647
Computed Tomography01:10

Computed Tomography

Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
9.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K